Antisense oligonucleotide reduction of DGAT2 expression improves hepatic steatosis and hyperlipidemia in obese mice-Reference-Cited by-同舟云学术

Antisense oligonucleotide reduction of DGAT2 expression improves hepatic steatosis and hyperlipidemia in obese mice

Published:2005 Issue:2 Volume:42 Page:362-371
ISSN:0270-9139
Container-title:Hepatology
language:en
Short-container-title:Hepatology

Author:

Yu Xing Xian,Murray Susan F.,Pandey Sanjay K.,Booten Sheri L.,Bao Dingjiu,Song Xiu-Zhen,Kelly Susan,Chen Songyuan,McKay Robert,Monia Brett P.,Bhanot Sanjay

Publisher

Wiley

Subject

Hepatology

Reference34 articles.

1. Molecular mediators of hepatic steatosis and liver injury

2. Obesity resistance and multiple mechanisms of triglyceride synthesis in mice lacking Dgat

3. Triglyceride synthesis: insights from the cloning of diacylglycerol acyltransferase

4. Identification of a gene encoding an acyl CoA:diacylglycerol acyltransferase, a key enzyme in triacylglycerol synthesis

5. Cloning of DGAT2, a Second Mammalian Diacylglycerol Acyltransferase, and Related Family Members

Cited by 251 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. DGAT1 and DGAT2 Inhibitors for Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) Management: Benefits for Their Single or Combined Application;International Journal of Molecular Sciences;2024-08-21

2. Updates on Rare Genetic Variants, Genetic Testing, and Gene Therapy in Individuals With Obesity;Current Obesity Reports;2024-06-01

3. Oligonucleotide therapies for nonalcoholic steatohepatitis;Molecular Therapy - Nucleic Acids;2024-06

4. MetALD: Does it require a different therapeutic option?;Hepatology;2024-05-31

5. Differences in diacylglycerol acyltransferases expression patterns and regulation cause distinct hepatic triglyceride deposition in fish;Communications Biology;2024-04-19